Acorda Therapeutics Inc (NASDAQ:ACOR)

32.17
Delayed Data
As of 9:39am ET
 -0.09 / -0.28%
Today’s Change
28.26
Today|||52-Week Range
45.45
-21.29%
Year-to-Date

Today’s Trading

Previous close32.26
Today’s open32.19
Day’s range32.09 - 32.19
Volume5,925
Average volume (3 months)658,364
Market cap$1.4B
Dividend yield--
Data as of 9:39am ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-172.63%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+19.34%
P/E ratio98.5
Price/Sales4.19
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
ZSPHZS Pharma Inc+2.65+4.69%
RGENRepligen Corp-0.05-0.12%
MACKMerrimack Pharmaceut...-0.04-0.32%
INSMInsmed Inc+0.08+0.35%
Data as of 9:52am ET, 05/22/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers